Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
28.1M
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
109M
-
Shares change
-
-4.56M
-
Total reported value, excl. options
-
$336M
-
Value change
-
-$23.7M
-
Put/Call ratio
-
2.19
-
Number of buys
-
52
-
Number of sells
-
-49
-
Price
-
$3.07
Significant Holders of GeneDx Holdings Corp. - Class A Common Stock (WGS) as of Q1 2022
136 filings reported holding WGS - GeneDx Holdings Corp. - Class A Common Stock as of Q1 2022.
GeneDx Holdings Corp. - Class A Common Stock (WGS) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 109M shares
.
Largest 10 shareholders include Blackstone Inc. (25.2M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (13.8M shares), SB Management Ltd (7.45M shares), VANGUARD GROUP INC (5.52M shares), Casdin Capital, LLC (5M shares), MARSHALL WACE, LLP (4.83M shares), Corvex Management LP (4.5M shares), Third Point LLC (4.3M shares), ORACLE INVESTMENT MANAGEMENT INC (3.94M shares), and Decheng Capital Management III (Cayman), LLC (3.42M shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.